Efficacy of dasatinib against ponatinib-resistant chronic myeloid leukemia cells

MLA

Akihiko Gotoh, et al. “Efficacy of Dasatinib against Ponatinib-Resistant Chronic Myeloid Leukemia Cells.” Leukemia & Lymphoma, vol. 61, Sept. 2019, pp. 237–39. EBSCOhost, https://doi.org/10.1080/10428194.2019.1660971.

APA

Akihiko Gotoh, Mitsuru Moriyama, Yuko Tanaka, & Seiichi Okabe. (2019). Efficacy of dasatinib against ponatinib-resistant chronic myeloid leukemia cells. Leukemia & Lymphoma, 61, 237–239. https://doi.org/10.1080/10428194.2019.1660971

Chicago

Akihiko Gotoh, Mitsuru Moriyama, Yuko Tanaka, and Seiichi Okabe. 2019. “Efficacy of Dasatinib against Ponatinib-Resistant Chronic Myeloid Leukemia Cells.” Leukemia & Lymphoma 61 (September): 237–39. doi:10.1080/10428194.2019.1660971.